Publications
Estimating risk of long COVID using a Bayesian network-based decision support tool
Sinclair JE, Mayfield HJ, Lu H, Brown SJ, Moghaddam T, Waller M, Bonner C, Williams O, Litt JCB, Short KR, Lau CL. Vaccine. 2026.
Beyond acute infection: mechanisms underlying post-acute sequelae of COVID-19
Adhikari A, Maddumage J, Eriksson EM, Annesley SJ, Lawson VA, Bryant VL, Gras S.
The Medical Journal of Australia. 2024.
A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
Missailidis D, Ebrahimie E, Dehcheshmeh MM, Allan C, Sanislav O, Fisher P, Gras S, Annesley SJ.
Frontiers in Immunology. 2024.
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
Rowntree LC, Audsley J, Allen LF, McQuilten HA, Hagen RR, Chaurasia P, Petersen J, Littler DR, Tan HX, Murdiyarso L, Habel JR, Foo IJH, Zhang W, Ten Berge ERV, Ganesh H, Kaewpreedee P, Lee KWK, Cheng SMS, Kwok JSY, Jayasinghe D, Gras S, et al.
PNAS. 2024.
Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection
Cooper L, Xu H, Polmear J, Kealy L, Szeto C, Pang ES, Gupta M, Kirn A, Taylor JJ, Jackson KJL, Broomfield BJ, Nguyen A, Gago da Graça C, La Gruta N, Utzschneider DT, Groom JR, Martelotto L, Parish IA, O’Keeffe M, Scharer CD, Gras S, Good-Jacobson KL.
Immunity. 2024.